BrainStorm Cell Therapeutics
BCLI
#9833
Rank
โ‚น0.10 B
Marketcap
โ‚น19.32
Share price
3.51%
Change (1 day)
16.34%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) Fails to deliver data

Key failure to deliver metrics for BrainStorm Cell Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BrainStorm Cell Therapeutics (BCLI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BrainStorm Cell Therapeutics (BCLI) - since 2014

Volume in USD (price x number of shares), data since 2014

BrainStorm Cell Therapeutics (BCLI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น1.43 M-89.59%
2023โ‚น13.79 M642.46%
2022โ‚น1.85 M-85.46%
2021โ‚น12.78 M-82.4%
2020โ‚น72.61 M2735.44%
2019โ‚น2.56 M157.62%
2018โ‚น0.99 M-51.31%
2017โ‚น2.04 M321.02%
2016โ‚น0.48 M-87.54%
2015โ‚น3.89 M1886.66%
2014โ‚น0.19 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
โ‚น50.53 Mโ‚น0.22 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.93 Mโ‚น0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aโ‚น15.56 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.56 Mโ‚น63.68 M๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aโ‚น4.77 M๐Ÿ‡บ๐Ÿ‡ธ USA